Our partnerships
Cancer Research Horizons partners across the fields of academia, industry, drug discovery and investors.
Medtech and diagnostics
Innovation in medtech and diagnostics is transforming cancer care for patients.
Our goal is to accelerate the translation of novel medical devices, biomarkers and diagnostics originating from Cancer Research UK-funded research into the clinic.
Partnering opportunities
Our researchers are developing biomarkers, diagnostics, medical devices, imaging technologies and computational tools to improve patient outcomes. We seek licensing and co-development partners to bring these innovations to market.
We are also open to other types of partnerships, such as workshops with our researchers to develop collaborative research projects and research partnerships focussed on our scientific infrastructure.
If you'd like to hear more, or explore an opportunity, please reach out to our team.
Licensing opportunities
We hold the rights to a wide variety of oncology-focused projects available for licensing or collaboration, including diagnostic methodologies and enabling technologies.
Cancer Tech Accelerator
We have established the Cancer Tech Accelerator in partnership with Capital Enterprise, MRC and Roche UK to help entrepreneurs develop their tech-enabled concepts into start-up companies.
